LANCE ALSTODT - 20 Mar 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: President, CEO, COB, Director, 10%+ Owner
Signature: /s/ Lance Alstodt
Issuer symbol: BRTX
Transactions as of: 20 Mar 2023
Transactions value $: -$19,649
Form type: 4
Filing time: 22 Mar 2023, 16:47:23 UTC
Previous filing: 27 Feb 2023
Next filing: 25 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRTX	Common Stock	Tax liability	-$19,648	-6,729	-3.6%	$2.92	180,218	20 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BRTX	Stock Option						293,479	20 Mar 2023	Common Stock	293,479	$5.08	Direct	F3
holding	BRTX	Stock Option						42,059	20 Mar 2023	Common Stock	42,059	$5.08	Direct	F4
holding	BRTX	Stock Option						106,762	20 Mar 2023	Common Stock	106,762	$2.91	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were withheld from vested stock grant to pay the associated withholding taxes.
F2	Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
F3	The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
F4	The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning on November 4, 2022 and continuing every three months thereafter until fully vested.
F5	The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.